Clinical Trials Browser

Phase 1/2 × Parkinson Disease 4, Autosomal Dominant Lewy Body × poly ICLC × Clear all

NCT02834052 2024-06-07

Pembrolizumab + Poly-ICLC in MRP Colon Cancer

Phase 1/2 Completed

42 enrolled 13 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms